FDA Approval of New COVID-19 Boosters Could Come by Friday
The new booster targets the XBB.1.5 omicron subvariant, which is similar to the dominant variant now circulating.
Diagnosis & Disease Information
5 Things to Know About the New Drug Pricing Negotiations
The Biden administration unveiled the first 10 drugs subject to price negotiations, taking a swipe at the pharmaceutical industry. But what does it mean for patients?
Latest 2023 FDA Approvals
Recent FDA approvals include treatments for postpartum depression, RSV in infants, pediatric constipation, metastatic colorectal cancer, and iron deficiency.
Recent 2023 FDA Approvals
Recent FDA approvals include treatments for chronic migraine, type 1 diabetes, blood cancers, tardive dyskinesia and chorea associated with Huntington disease, vasomotor symptoms of menopause, pain and fever, and Fabry disease.
Federal Rules Don’t Require Period Product Ingredients on Packaging Labels. States Are Stepping In
Although two states have passed laws requiring the disclosure of ingredients on menstrual product packaging, advocates want more transparency across the US.
FDA Clears Patch Therapy to Reduce Excessive Underarm Sweating in Adults
Brella is a single-use disposable patch consisting of a sodium sheet with an adhesive overlay that is applied to a patient’s underarm by a health care provider for up to 3 minutes.
FDA Clears Implantable Shock Absorber to Treat Knee Osteoarthritis
The device is implanted subcutaneously during an outpatient-compatible procedure.
FDA Clears Monitoring Device That Detects Opioid-Induced Respiratory Depression
Using a tetherless, adhesive fingertip sensor, the device monitors several physiological markers to detect the impairment of oxygenation due to opioid use.
FDA Requires Manufacturers to Provide Mail-Back Envelopes for Opioid Disposal
Approval of the modified Opioid Analgesic REMS is expected in 2024.
Top March 2023 FDA Approvals
March FDA approvals include treatments for candidemia and invasive candidiasis, sleep apnea for children with Down syndrome, pediatric BRAF V600E low-grade glioma, and migraines.
- Loading...
Loading...
Next post in General Medicine
Loading... 
Loading...